BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12370857)

  • 1. Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus.
    Ikewaki K; Mochizuki K; Iwasaki M; Nishide R; Mochizuki S; Tada N
    Metabolism; 2002 Oct; 51(10):1348-54. PubMed ID: 12370857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
    Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
    J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?
    Rizzo M; Corrado E; Patti AM; Rini GB; Mikhailidis DP
    Expert Opin Pharmacother; 2011 Mar; 12(4):647-55. PubMed ID: 21284580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
    Syvänne M; Hilden H; Taskinen MR
    J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA; Stentz F; Gettys T; Smith SR
    Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age.
    Karpe F; Bard JM; Steiner G; Carlson LA; Fruchart JC; Hamsten A
    Arterioscler Thromb; 1993 Jan; 13(1):11-22. PubMed ID: 8422332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial lipemia in diabetic men during hypolipemic therapy.
    Skoczyńska A; Kreczyńska B; Poreba R
    Pol Arch Med Wewn; 2009; 119(7-8):461-8. PubMed ID: 19776686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
    Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.
    Reznik Y; Pousse P; Herrou M; Morello R; Mahoudeau J; Drosdowsky MA; Fradin S
    Metabolism; 1996 Jan; 45(1):63-71. PubMed ID: 8544779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.
    Liu Y; Shakur Y; Yoshitake M; Kambayashi Ji J
    Cardiovasc Drug Rev; 2001; 19(4):369-86. PubMed ID: 11830753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
    Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial plasma lipidome responses to a high-fat meal among healthy women.
    Yoshinaga MY; Quintanilha BJ; Chaves-Filho AB; Miyamoto S; Sampaio GR; Rogero MM
    J Nutr Biochem; 2021 Nov; 97():108809. PubMed ID: 34192591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corn oil and beef tallow elicit different postprandial responses in triglycerides and cholesterol, but similar changes in constituents of high-density lipoprotein.
    Muesing RA; Griffin P; Mitchell P
    J Am Coll Nutr; 1995 Feb; 14(1):53-60. PubMed ID: 7706611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan.
    Kobayashi J; Saito Y; Taira K; Hikita M; Takahashi K; Bujo H; Morisaki N; Saito Y
    Atherosclerosis; 2001 Feb; 154(3):539-46. PubMed ID: 11257254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum triglycerides and high-density lipoprotein concentration and composition after a low-fat mixed meal. Effects of gender and insulin resistance.
    Branchi A; Torri A; Berra C; Colombo E; Sommariva D
    Intern Emerg Med; 2006; 1(4):287-95. PubMed ID: 17217150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes.
    Tan KC; Tso AW; Ma OC; Pang RW; Tam S; Lam KS
    Diabetes Metab Res Rev; 2005; 21(2):209-14. PubMed ID: 15386805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between high density lipoprotein subclass profile and plasma lipids concentrations.
    Tian L; Fu M
    Lipids Health Dis; 2010 Oct; 9():118. PubMed ID: 20950490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0).
    Tilly-Kiesi M; Lichtenstein AH; Rintarahko J; Taskinen MR
    Atherosclerosis; 1998 Mar; 137(1):37-47. PubMed ID: 9568735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.